LUCYW
Financials
- Market Capitalization 274.6334 K
- Employee 13
- Founded 2019
- CEO N/A
- Website www.lucyd.co
- Headquarter Florida, United States
- FIGI BBG016ZDKY38
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4970 |  NXGL NexGel, Inc - Common Stock | 3.81 USD | +1805.00% | +2141.18% | +1213.79% | +49.41% | 1.86 M USD | ||
| 5017 |  GCTK GlucoTrack, Inc. - Common Stock | 1.16 USD | +12.62% | +3.57% | -53.60% | -29.27% | 818.10 K USD | ||
| 7276 |  NXGLW NexGel, Inc - Warrant | 0.0090 USD | 0.00% | -21.74% | -31.30% | -97.02% | 1.86 M USD | ||
| 7294 |  LUCY Innovative Eyewear, Inc. - Common Stock | 0.88 USD | -2.22% | -1.12% | +6.02% | -20.72% | 274.63 K USD |
Frequently asked questions about Innovative Eyewear, Inc. Series A Warrants 8/16/27
What is the Innovative Eyewear, Inc. Series A Warrants 8/16/27 stock price today?
The current price of Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) is 0.0319. Over the past 24 hours, the stock has changed by -3.03%. Follow the LUCYW chart for real-time price dynamics.
What is the stock ticker of Innovative Eyewear, Inc. Series A Warrants 8/16/27?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 trades under the ticker LUCYW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Innovative Eyewear, Inc. Series A Warrants 8/16/27 stock going up?
LUCYW has changed by +13.93% over the last week, -9.63% over the last month, and -71.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Innovative Eyewear, Inc. Series A Warrants 8/16/27?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 currently has a market capitalization of 274.63 K. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Innovative Eyewear, Inc. Series A Warrants 8/16/27 earnings last quarter?
Last quarter, Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported earnings of -0.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Innovative Eyewear, Inc. Series A Warrants 8/16/27 revenue for the last quarter?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported quarterly revenue of 1.01 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Innovative Eyewear, Inc. Series A Warrants 8/16/27 net income for the last quarter?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported net income of -1.67 M for the last quarter. The previous quarter showed -2.31 M, which means net income changed by +27.65%.
How many employees does Innovative Eyewear, Inc. Series A Warrants 8/16/27 have?
As of the latest available data, Innovative Eyewear, Inc. Series A Warrants 8/16/27 has 13 employees. Workforce size can provide additional context about the company's scale and operations.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27 EBITDA?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 EBITDA is -1.7 M, and its EBITDA margin is -167.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Innovative Eyewear, Inc. Series A Warrants 8/16/27 stock?
You can buy Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Innovative Eyewear, Inc. Series A Warrants 8/16/27 stock?
Investing in Innovative Eyewear, Inc. Series A Warrants 8/16/27 requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LUCYW chart and related analysis on metatrader.com as part of your research.